Xtx Topco LTD Tempest Therapeutics, Inc. Transaction History
Xtx Topco LTD
- $1.13 Billion
- Q4 2024
A detailed history of Xtx Topco LTD transactions in Tempest Therapeutics, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 160,807 shares of TPST stock, worth $149,550. This represents 0.01% of its overall portfolio holdings.
Number of Shares
160,807
Previous 23,989
570.34%
Holding current value
$149,550
Previous $33,000
309.09%
% of portfolio
0.01%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding TPST
# of Institutions
38Shares Held
5.53MCall Options Held
44.9KPut Options Held
109K-
Versant Venture Management, LLC San Francisco, CA3.51MShares$3.26 Million4.35% of portfolio
-
Black Rock Inc. New York, NY550KShares$511,7240.0% of portfolio
-
Geode Capital Management, LLC Boston, MA354KShares$329,4760.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA176KShares$163,8590.0% of portfolio
-
Fil LTD Hamilton, D0130KShares$120,5080.0% of portfolio
About Tempest Therapeutics, Inc.
- Ticker TPST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,418,900
- Market Cap $9.69M
- Description
- Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxiso...